⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IVVD News
Invivyd, Inc. Common Stock
Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
globenewswire.com
IVVD
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire.com
GSK
BIIB
NVS
BMY
REGN
VRTX
LLY
MRK
ALNY
IVVD
ALE
SCHR
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
globenewswire.com
IVVD
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
globenewswire.com
IVVD
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
globenewswire.com
IVVD
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
globenewswire.com
IVVD
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
globenewswire.com
IVVD
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
IVVD
Invivyd Announces Proposed Public Offering of Common Stock
globenewswire.com
IVVD
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
IVVD